Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,707 shares at $950.00 ($2.6M) on 2024-01-23, disclosed to the SEC on 2024-01-25.
Scheduled sale ($2.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |
| REGN | SELL | 2020-10-06 | $5.5M | — | Filing → |